Lupus Heart Disease Modeling with Combination of Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Lupus Patient Serum
Authors:
Open Access
- 31 December 2021
- journal article
- research article
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 15 (3) , 233-246
Abstract
Narae Park, Yeri Alice Rim, Hyerin Jung, Yoojun Nam, Ji Hyeon Ju. IJSC 2022;15:233-46. https://doi.org/10.15283/ijsc21158Keywords
Funding Information
- Ministry for Health, Welfare and Family Affairs (HI16C2177)
- Ministry of Science and ICT (NRF-2019R1A5A2027588, NRF-2020R 1A1C3004123, NRF-2021R1C1C2004688)
This publication has 38 references indexed in Scilit:
- Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiationJournal of Experimental Medicine, 2012
- Clinical and Pathological Roles of Ro/SSA Autoantibody SystemJournal of Immunology Research, 2012
- Cardiomyocyte death: mechanisms and translational implicationsCell Death & Disease, 2011
- Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantationStem Cell Research & Therapy, 2011
- Harnessing the potential of induced pluripotent stem cells for regenerative medicineNature Cell Biology, 2011
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJACC, 2009
- Anti‐LA/SSB antiidiotypic antibodies in maternal serum: A marker of low risk for neonatal lupus in an offspringArthritis & Rheumatism, 2006
- Anti-Ro/SSA and La/SSB antibodiesAutoimmunity, 2005
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Localization of ro (ss‐a) antigen in the cardiac conduction systemArthritis & Rheumatism, 1987